New Clinical Trial Site Now Enrolling – OSUCCC-James Joins ReSPECT-GBM!
We are excited to announce that The Ohio State University Comprehensive Cancer Center – James (OSUCCC – James) has joined our ReSPECT-GBM Clinical Trial as a new investigation site, with Principal Investigator Pierre Giglio, M.D..
Now Enrolling Patients for ReSPECT-GBM & ReSPECT-LM Trials
📍 New Site: OSUCCC – James
👨⚕️ Principal Investigator: Dr. Pierre Giglio, M.D.
– Specialist in over 35 nervous system cancers
– Research focus on glioblastoma (GBM)
– Named a Castle Connolly “Regional Top Doctor” (2015–2019)
Dr. Giglio, a highly regarded neuro-oncologist and associate professor of neurology, is passionate about advancing glioblastoma research. He works alongside leading cancer researchers and clinicians in neuro-oncology to develop groundbreaking treatments for brain cancer patients.
Learn More & Enroll Today
🔬 Interested in participating? Find out more about the ReSPECT-GBM Clinical Trial and connect with Dr. Giglio’s patient coordinator:
🔗 Learn About ReSPECT-GBM
Dr. Giglio is also the Principal Investigator for the ReSPECT-LM Clinical Trial at OSU, focused on leptomeningeal metastases (LM):
🔗 Learn About ReSPECT-LM
#ClinicalTrials #CancerResearch #Glioblastoma #BrainCancer #NeuroOncology #LeptomeningealMetastases #LMD #GBM
Recent Comments